Indeed, several reports have described the feasibility of using these cells as anti-cancer delivery vehicles because they secrete various anti-cancer molecules such as tissue necrosis factor (TNF), TNF related apoptosis inducing ligand (TRAIL), and interferon (IFN)-β by transfection. This evidence concerns the gene IFNB1 and cancer.